U.S. Supreme Court Hikma Pharmaceuticals v. Amarin Pharma, Case No. 24-889 episode artwork

EPISODE · Apr 29, 2026

U.S. Supreme Court Hikma Pharmaceuticals v. Amarin Pharma, Case No. 24-889

from Audio Arguendo · host U.S. Supreme Court

Administrative Law: When a generic drug label fully carves out a patented use, are allegations that the generic drugmaker calls its product a "generic version" and cites public information about the branded drug enough to plead induced infringement of the patented use? - Argued: Wed, 29 Apr 2026 13:44:54 EDT

NOW PLAYING

U.S. Supreme Court Hikma Pharmaceuticals v. Amarin Pharma, Case No. 24-889

0:00 0:00

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Audio Arguendo?

Episode duration information is not available.

When was this Audio Arguendo episode published?

This episode was published on April 29, 2026.

What is this episode about?

Administrative Law: When a generic drug label fully carves out a patented use, are allegations that the generic drugmaker calls its product a "generic version" and cites public information about the branded drug enough to plead induced infringement...

Can I download this Audio Arguendo episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!